Clinical trials
Tonsillitis trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
38 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 2 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 3 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 6 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Unknown status | 8 |
| Recruiting | 6 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Suspended | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Oulu University Hospital | 2 |
| Turku University Hospital | 2 |
| AB Biotics, SA | 1 |
| Ain Shams University | 1 |
| Ajou University School of Medicine | 1 |
| Alaa Emara | 1 |
| Assistance Publique Hopitaux De Marseille | 1 |
| Bait Balev Hospital | 1 |
| Boston Children's Hospital | 1 |
| Chulalongkorn University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tonsillitis | 38 |
| Pharyngitis | 6 |
| Sleep Apnea, Obstructive | 5 |
| Pain | 4 |
| Respiratory Tract Infections | 3 |
| Hyperthermia | 2 |
| Otitis Media | 2 |
| Peritonsillar Abscess | 2 |
| Sleep Apnea Syndromes | 2 |
| Agnosia | 1 |
Trials
Showing 26 to 38 of 38. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.